APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Plasma

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Blood Plasma Market Outlook and Growth Opportunities 2026

22 December 2025195 pages

Choose your research edition.

Industry ResearchBlood Plasma Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Plasma Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Blood Plasma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Plasma Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Plasma Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Blood Plasma market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Blood Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Blood Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blood Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Blood Plasma market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Blood Plasma market include Shanghai Raas, Baxter International, TCS Biosciences, Sanquin, Octapharma, Grifols, CSL, Cerus Corp and ADMA Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Blood Plasma market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Blood Plasma and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blood Plasma sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Blood Plasma market size, projected growth trends, production technologies, key applications, and end-use industries.

Blood Plasma Segment by Company

Shanghai Raas

Baxter International

TCS Biosciences

Sanquin

Octapharma

Grifols

CSL

Cerus Corp

ADMA Biologics

Blood Plasma Segment by Type

Protease Inhibitors

Coagulation Factor Concentrates

Immunoglobulin

Albumin

Others

Blood Plasma Segment by Application

Hospitals and Clinics

Research Laboratories

Academic Institutions

Blood Plasma Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Blood Plasma status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Blood Plasma market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Blood Plasma significant trends, drivers, influence factors in global and regions.

6. To analyze Blood Plasma competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Plasma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Plasma and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Plasma.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Blood Plasma market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Plasma industry.

Chapter 3: Detailed analysis of Blood Plasma manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Blood Plasma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Blood Plasma in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Blood Plasma Industry Trends Table 2. Blood Plasma Industry Drivers Table 3. Blood Plasma Industry Opportunities and Challenges Table 4. Blood Plasma Industry Restraints Table 5. Global Blood Plasma Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Blood Plasma Revenue Share by Company (2021-2026) Table 7. Global Blood Plasma Sales Volume by Company (k units) & (2021-2026) Table 8. Global Blood Plasma Sales Volume Share by Company (2021-2026) Table 9. Global Blood Plasma Average Price (US$/unit) of Company (2021-2026) Table 10. Global Blood Plasma Company Ranking, (2024-2026) & (USD Million) Table 11. Global Blood Plasma Key Company Manufacturing Base & Headquarters Table 12. Global Blood Plasma Company, Product Type & Application Table 13. Global Blood Plasma Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Blood Plasma by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Protease Inhibitors Table 18. Significant Companies of Coagulation Factor Concentrates Table 19. Significant Companies of Immunoglobulin Table 20. Significant Companies of Albumin Table 21. Significant Companies of Others Table 22. Global Blood Plasma Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Blood Plasma Sales Volume by Type (2021-2026) & (k units) Table 24. Global Blood Plasma Sales Volume by Type (2027-2032) & (k units) Table 25. Global Blood Plasma Sales Volume Share by Type (2021-2026) Table 26. Global Blood Plasma Sales Volume Share by Type (2027-2032) Table 27. Global Blood Plasma Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Blood Plasma Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Blood Plasma Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Blood Plasma Sales Value Share by Type (2021-2026) Table 31. Global Blood Plasma Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospitals and Clinics Table 33. Significant Companies of Research Laboratories Table 34. Significant Companies of Academic Institutions Table 35. Global Blood Plasma Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Blood Plasma Sales Volume by Application (2021-2026) & (k units) Table 37. Global Blood Plasma Sales Volume by Application (2027-2032) & (k units) Table 38. Global Blood Plasma Sales Volume Share by Application (2021-2026) Table 39. Global Blood Plasma Sales Volume Share by Application (2027-2032) Table 40. Global Blood Plasma Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Blood Plasma Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Blood Plasma Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Blood Plasma Sales Value Share by Application (2021-2026) Table 44. Global Blood Plasma Sales Value Share by Application (2027-2032) Table 45. Global Blood Plasma Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Blood Plasma Sales by Region (2021-2026) & (k units) Table 47. Global Blood Plasma Sales Market Share by Region (2021-2026) Table 48. Global Blood Plasma Sales by Region (2027-2032) & (k units) Table 49. Global Blood Plasma Sales Market Share by Region (2027-2032) Table 50. Global Blood Plasma Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Blood Plasma Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Blood Plasma Sales Value Share by Region (2021-2026) Table 53. Global Blood Plasma Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Blood Plasma Sales Value Share by Region (2027-2032) Table 55. Global Blood Plasma Market Average Price (US$/unit) by Region (2021-2026) Table 56. Global Blood Plasma Market Average Price (US$/unit) by Region (2027-2032) Table 57. Global Blood Plasma Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Blood Plasma Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Blood Plasma Sales by Country (2021-2026) & (k units) Table 60. Global Blood Plasma Sales Market Share by Country (2021-2026) Table 61. Global Blood Plasma Sales by Country (2027-2032) & (k units) Table 62. Global Blood Plasma Sales Market Share by Country (2027-2032) Table 63. Global Blood Plasma Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Blood Plasma Sales Value Market Share by Country (2021-2026) Table 65. Global Blood Plasma Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Blood Plasma Sales Value Market Share by Country (2027-2032) Table 67. Shanghai Raas Company Information Table 68. Shanghai Raas Business Overview Table 69. Shanghai Raas Blood Plasma Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Shanghai Raas Blood Plasma Product Portfolio Table 71. Shanghai Raas Recent Development Table 72. Baxter International Company Information Table 73. Baxter International Business Overview Table 74. Baxter International Blood Plasma Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Baxter International Blood Plasma Product Portfolio Table 76. Baxter International Recent Development Table 77. TCS Biosciences Company Information Table 78. TCS Biosciences Business Overview Table 79. TCS Biosciences Blood Plasma Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. TCS Biosciences Blood Plasma Product Portfolio Table 81. TCS Biosciences Recent Development Table 82. Sanquin Company Information Table 83. Sanquin Business Overview Table 84. Sanquin Blood Plasma Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Sanquin Blood Plasma Product Portfolio Table 86. Sanquin Recent Development Table 87. Octapharma Company Information Table 88. Octapharma Business Overview Table 89. Octapharma Blood Plasma Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Octapharma Blood Plasma Product Portfolio Table 91. Octapharma Recent Development Table 92. Grifols Company Information Table 93. Grifols Business Overview Table 94. Grifols Blood Plasma Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Grifols Blood Plasma Product Portfolio Table 96. Grifols Recent Development Table 97. CSL Company Information Table 98. CSL Business Overview Table 99. CSL Blood Plasma Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. CSL Blood Plasma Product Portfolio Table 101. CSL Recent Development Table 102. Cerus Corp Company Information Table 103. Cerus Corp Business Overview Table 104. Cerus Corp Blood Plasma Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Cerus Corp Blood Plasma Product Portfolio Table 106. Cerus Corp Recent Development Table 107. ADMA Biologics Company Information Table 108. ADMA Biologics Business Overview Table 109. ADMA Biologics Blood Plasma Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. ADMA Biologics Blood Plasma Product Portfolio Table 111. ADMA Biologics Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Blood Plasma Distributors List Table 115. Blood Plasma Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Blood Plasma Product Image Figure 2. Global Blood Plasma Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Plasma Sales Value (2021-2032) & (US$ Million) Figure 4. Global Blood Plasma Sales (2021-2032) & (k units) Figure 5. Global Blood Plasma Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Blood Plasma Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Protease Inhibitors Image Figure 10. Coagulation Factor Concentrates Image Figure 11. Immunoglobulin Image Figure 12. Albumin Image Figure 13. Others Image Figure 14. Global Blood Plasma Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Blood Plasma Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Blood Plasma Sales Volume Share by Type (2021-2032) Figure 17. Global Blood Plasma Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Blood Plasma Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Blood Plasma Sales Value Share by Type (2021-2032) Figure 20. Hospitals and Clinics Image Figure 21. Research Laboratories Image Figure 22. Academic Institutions Image Figure 23. Global Blood Plasma Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Blood Plasma Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Blood Plasma Sales Volume Share by Application (2021-2032) Figure 26. Global Blood Plasma Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Blood Plasma Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Blood Plasma Sales Value Share by Application (2021-2032) Figure 29. Global Blood Plasma Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Blood Plasma Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Blood Plasma Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Blood Plasma Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Blood Plasma Sales Value (2021-2032) & (US$ Million) Figure 34. North America Blood Plasma Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Blood Plasma Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Blood Plasma Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Blood Plasma Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Blood Plasma Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Blood Plasma Sales Value (2021-2032) & (US$ Million) Figure 40. South America Blood Plasma Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Blood Plasma Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Blood Plasma Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Blood Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Blood Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Blood Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Blood Plasma Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Blood Plasma Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Protease Inhibitors
  • Coagulation Factor Concentrates
  • Immunoglobulin
  • Albumin
  • Others
Applications
  • Hospitals and Clinics
  • Research Laboratories
  • Academic Institutions
Companies covered
  • Shanghai Raas
  • Baxter International
  • TCS Biosciences
  • Sanquin
  • Octapharma
  • Grifols
  • CSL
  • Cerus Corp
  • ADMA Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Blood Plasma Sales Value (2021-2032)
  4. 1.2.2 Global Blood Plasma Sales Volume (2021-2032)
  5. 1.2.3 Global Blood Plasma Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Blood Plasma Market Dynamics
  1. 2.1 Blood Plasma Industry Trends
  2. 2.2 Blood Plasma Industry Drivers
  3. 2.3 Blood Plasma Industry Opportunities and Challenges
  4. 2.4 Blood Plasma Industry Restraints
3 Blood Plasma Market by Company
  1. 3.1 Global Blood Plasma Company Revenue Ranking in 2025
  2. 3.2 Global Blood Plasma Revenue by Company (2021-2026)
  3. 3.3 Global Blood Plasma Sales Volume by Company (2021-2026)
  4. 3.4 Global Blood Plasma Average Price by Company (2021-2026)
  5. 3.5 Global Blood Plasma Company Ranking (2024-2026)
  6. 3.6 Global Blood Plasma Company Manufacturing Base and Headquarters
  7. 3.7 Global Blood Plasma Company Product Type and Application
  8. 3.8 Global Blood Plasma Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Blood Plasma Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Blood Plasma Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Blood Plasma Market by Type
  1. 4.1 Blood Plasma Type Introduction
  2. 4.1.1 Protease Inhibitors
  3. 4.1.2 Coagulation Factor Concentrates
  4. 4.1.3 Immunoglobulin
  5. 4.1.4 Albumin
  6. 4.1.5 Others
  7. 4.2 Global Blood Plasma Sales Volume by Type
  8. 4.2.1 Global Blood Plasma Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Blood Plasma Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Blood Plasma Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Blood Plasma Sales Value by Type
  12. 4.3.1 Global Blood Plasma Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Blood Plasma Sales Value by Type (2021-2032)
  14. 4.3.3 Global Blood Plasma Sales Value Share by Type (2021-2032)
5 Blood Plasma Market by Application
  1. 5.1 Blood Plasma Application Introduction
  2. 5.1.1 Hospitals and Clinics
  3. 5.1.2 Research Laboratories
  4. 5.1.3 Academic Institutions
  5. 5.2 Global Blood Plasma Sales Volume by Application
  6. 5.2.1 Global Blood Plasma Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Blood Plasma Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Blood Plasma Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Blood Plasma Sales Value by Application
  10. 5.3.1 Global Blood Plasma Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Blood Plasma Sales Value by Application (2021-2032)
  12. 5.3.3 Global Blood Plasma Sales Value Share by Application (2021-2032)
6 Blood Plasma Regional Sales and Value Analysis
  1. 6.1 Global Blood Plasma Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Blood Plasma Sales by Region (2021-2032)
  3. 6.2.1 Global Blood Plasma Sales by Region: 2021-2026
  4. 6.2.2 Global Blood Plasma Sales by Region (2027-2032)
  5. 6.3 Global Blood Plasma Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Blood Plasma Sales Value by Region (2021-2032)
  7. 6.4.1 Global Blood Plasma Sales Value by Region: 2021-2026
  8. 6.4.2 Global Blood Plasma Sales Value by Region (2027-2032)
  9. 6.5 Global Blood Plasma Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Blood Plasma Sales Value (2021-2032)
  12. 6.6.2 North America Blood Plasma Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Blood Plasma Sales Value (2021-2032)
  15. 6.7.2 Europe Blood Plasma Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Blood Plasma Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Blood Plasma Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Blood Plasma Sales Value (2021-2032)
  21. 6.9.2 South America Blood Plasma Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Blood Plasma Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Blood Plasma Sales Value Share by Country, 2025 VS 2032
7 Blood Plasma Country-level Sales and Value Analysis
  1. 7.1 Global Blood Plasma Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Blood Plasma Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Blood Plasma Sales by Country (2021-2032)
  4. 7.3.1 Global Blood Plasma Sales by Country (2021-2026)
  5. 7.3.2 Global Blood Plasma Sales by Country (2027-2032)
  6. 7.4 Global Blood Plasma Sales Value by Country (2021-2032)
  7. 7.4.1 Global Blood Plasma Sales Value by Country (2021-2026)
  8. 7.4.2 Global Blood Plasma Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Blood Plasma Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Blood Plasma Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Blood Plasma Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Blood Plasma Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Blood Plasma Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Blood Plasma Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Blood Plasma Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Blood Plasma Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Blood Plasma Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Blood Plasma Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Blood Plasma Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Blood Plasma Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Blood Plasma Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Blood Plasma Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Blood Plasma Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Blood Plasma Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Blood Plasma Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Blood Plasma Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Blood Plasma Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Blood Plasma Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Blood Plasma Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Blood Plasma Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Blood Plasma Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Blood Plasma Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Blood Plasma Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Blood Plasma Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Blood Plasma Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Blood Plasma Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Blood Plasma Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Blood Plasma Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Blood Plasma Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Blood Plasma Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Blood Plasma Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Blood Plasma Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Blood Plasma Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Blood Plasma Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Blood Plasma Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Blood Plasma Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Blood Plasma Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Blood Plasma Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Blood Plasma Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Blood Plasma Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Blood Plasma Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Blood Plasma Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Blood Plasma Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Blood Plasma Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Blood Plasma Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Blood Plasma Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Blood Plasma Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Blood Plasma Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Blood Plasma Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Blood Plasma Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Blood Plasma Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Blood Plasma Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Blood Plasma Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Blood Plasma Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Blood Plasma Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Blood Plasma Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Blood Plasma Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Blood Plasma Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Blood Plasma Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Blood Plasma Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Blood Plasma Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Blood Plasma Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Blood Plasma Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Blood Plasma Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Blood Plasma Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Blood Plasma Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Blood Plasma Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Blood Plasma Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Blood Plasma Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Blood Plasma Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Blood Plasma Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Blood Plasma Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Blood Plasma Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Blood Plasma Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Blood Plasma Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Blood Plasma Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Blood Plasma Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Blood Plasma Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Blood Plasma Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Blood Plasma Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Blood Plasma Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Blood Plasma Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shanghai Raas
  2. 8.1.1 Shanghai Raas Company Information
  3. 8.1.2 Shanghai Raas Business Overview
  4. 8.1.3 Shanghai Raas Blood Plasma Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Shanghai Raas Blood Plasma Product Portfolio
  6. 8.1.5 Shanghai Raas Recent Developments
  7. 8.2 Baxter International
  8. 8.2.1 Baxter International Company Information
  9. 8.2.2 Baxter International Business Overview
  10. 8.2.3 Baxter International Blood Plasma Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Baxter International Blood Plasma Product Portfolio
  12. 8.2.5 Baxter International Recent Developments
  13. 8.3 TCS Biosciences
  14. 8.3.1 TCS Biosciences Company Information
  15. 8.3.2 TCS Biosciences Business Overview
  16. 8.3.3 TCS Biosciences Blood Plasma Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 TCS Biosciences Blood Plasma Product Portfolio
  18. 8.3.5 TCS Biosciences Recent Developments
  19. 8.4 Sanquin
  20. 8.4.1 Sanquin Company Information
  21. 8.4.2 Sanquin Business Overview
  22. 8.4.3 Sanquin Blood Plasma Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sanquin Blood Plasma Product Portfolio
  24. 8.4.5 Sanquin Recent Developments
  25. 8.5 Octapharma
  26. 8.5.1 Octapharma Company Information
  27. 8.5.2 Octapharma Business Overview
  28. 8.5.3 Octapharma Blood Plasma Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Octapharma Blood Plasma Product Portfolio
  30. 8.5.5 Octapharma Recent Developments
  31. 8.6 Grifols
  32. 8.6.1 Grifols Company Information
  33. 8.6.2 Grifols Business Overview
  34. 8.6.3 Grifols Blood Plasma Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Grifols Blood Plasma Product Portfolio
  36. 8.6.5 Grifols Recent Developments
  37. 8.7 CSL
  38. 8.7.1 CSL Company Information
  39. 8.7.2 CSL Business Overview
  40. 8.7.3 CSL Blood Plasma Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 CSL Blood Plasma Product Portfolio
  42. 8.7.5 CSL Recent Developments
  43. 8.8 Cerus Corp
  44. 8.8.1 Cerus Corp Company Information
  45. 8.8.2 Cerus Corp Business Overview
  46. 8.8.3 Cerus Corp Blood Plasma Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Cerus Corp Blood Plasma Product Portfolio
  48. 8.8.5 Cerus Corp Recent Developments
  49. 8.9 ADMA Biologics
  50. 8.9.1 ADMA Biologics Company Information
  51. 8.9.2 ADMA Biologics Business Overview
  52. 8.9.3 ADMA Biologics Blood Plasma Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 ADMA Biologics Blood Plasma Product Portfolio
  54. 8.9.5 ADMA Biologics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Blood Plasma Value Chain Analysis
  2. 9.1.1 Blood Plasma Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Blood Plasma Sales Mode & Process
  6. 9.2 Blood Plasma Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Blood Plasma Distributors
  9. 9.2.3 Blood Plasma Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst